Related content

Reduction in pediatric invasive pneumococcal disease in the Basque Country and Navarre, Spain, after introduction of the heptavalent pneumococcal conjugate vaccine

By Aristegui J.   Bernaola E.   Pocheville I.   García C.   Arranz L.   Durán G.   Pérez L.   Bastida M.   Canduela C.   Herranz Aguirre M.   Garrote E.   Fletcher M.   Pérez C.  

European Journal of Clinical Microbiology and Infectious Diseases, Vol. 26, Iss. 5, 2007-05 ,pp. : 303-310

Springer Publishing Company

Access to resources Recommend Favorite

Invasive pneumococcal disease in children up to 5 years of age in Poland

By Grzesiowski P.   Skoczynska A.   Albrecht P.   Konior R.   Patrzalek M.   Sadowska M.   Staroszczyk J.   Szenborn L.   Wysocki J.   Hryniewicz W.  

European Journal of Clinical Microbiology and Infectious Diseases, Vol. 27, Iss. 9, 2008-09 ,pp. : 883-885

Springer Publishing Company

Access to resources Recommend Favorite

Mucosal immune responses to pneumococcal polysaccharides: implications for vaccination

By van den Dobbelsteen G.P.J.M.   van Rees E.P.  

Trends in Microbiology, Vol. 3, Iss. 4, 1995-04 ,pp. : 155-159

Elsevier

Access to resources Recommend Favorite

Serotype-specific problems associated with pneumococcal conjugate vaccination

By Hanage William P  

Future Microbiology, Vol. 3, Iss. 1, 2008-02 ,pp. : 23-30

Future Medicine

Access to resources Recommend Favorite

Update on invasive fungal disease

By Pagano Livio   Lumb Joanna  

Future Microbiology, Vol. 6, Iss. 9, 2011-09 ,pp. : 985-989

Future Medicine

Access to resources Recommend Favorite